Search results for "Biopharmaceutical"

showing 5 items of 35 documents

Governance forms drivers in bio-pharmaceutial inter-firm relationships

2012

Networking benefits are acknowledged by many studies in the industrial organization and strategic management fields; transaction cost theory agency and property right theory provide the economic foundations to the market-hierarchy dilemma; while Resource based-view (RBV), relational and evolutionary theories provide the strategic foundation of the inter-firm relationships. All this theoretical strands investigate reasons that push firms to formalize their relationship in different governance structures. The bio-pharmaceutical industry has the characteristics to offer to the potential partners both exploitation or exploration alliances benefits. In particular some elements play a “pivot” rol…

Transaction costEconomics and EconometricsGovernance formCorporate governanceEquity (finance)Face (sociological concept)RationalityManagement Science and Operations ResearchInvestment (macroeconomics)Settore ING-IND/35 - Ingegneria Economico-GestionaleGeneral Business Management and AccountingIndustrial and Manufacturing EngineeringSecondary data sourceBio-pharmaceutical industry secondary data source governance formsBiopharmaceutical industryMergers and acquisitionsBio-pharmaceutical industryEconomicsMarketingIndustrial organization
researchProduct

Drivers influencing the governance of inter-firm relationships in the biopharmaceutical industry: an empirical survey in the Italian context

2013

This paper focuses on factors influencing the choice of the governance form in inter-firm relationships (IFRs) between pharmaceutical and biotechnology companies. By reviewing the relevant literature on transaction cost economics, property right theory, real option and resources-based view, we located some drivers that might influence such relationships and we formulated a set of hypotheses linking them to governance forms. Such a theoretical framework has been empirically tested through a survey conducted among the Italian companies associated to Farmindustria. Empirical results provide some interesting insights on how shaping bio-pharmaceutical deals; we found that the developmental stage…

Transaction costStrategy and ManagementCorporate governanceContext (language use)Management Science and Operations Researchinter-firm relationshipSettore ING-IND/35 - Ingegneria Economico-GestionaleObject (philosophy)governance formbiopharmaceutical industry; governance form; inter-firm relationship; surveyBiopharmaceutical industryProperty rightsbiopharmaceutical industrysurveyProduct (category theory)BusinessMarketingSet (psychology)Industrial organizationTechnology Analysis & Strategic Management
researchProduct

BIOPHARMACEUTICAL ALLIANCES AND COMPETITION: A REAL OPTIONS GAMES APPROACH

2013

The competitive landscape where pharmaceutical and biotechnology companies operate has changed radically due to a scientific/technological progress that has revolutionised the process by which drugs are developed. In fact, pharmaceutical industry more and more relies on advances in biochemistry and molecular biology. As a consequence, the number of partnerships between pharmaceutical and biotech firms has grown significantly. Research contributions addressing the biopharmaceutical alliances design have also focused on the optimal timing to sign a partnership. In this paper, we introduce and analyse the effect of competition in biotechnology industry by modelling the decisions of whether and…

business.industryTechnological changeProcess (engineering)Strategy and ManagementSettore ING-IND/35 - Ingegneria Economico-Gestionalereal options games.Biopharmaceutical alliances competition real options gamesCompetition (economics)AllianceBiopharmaceuticalBiopharmaceutical allianceManagement of Technology and InnovationGeneral partnershipEconomicsFirst-mover advantageBusiness and International ManagementMarketingbusinesscompetitionPharmaceutical industryInternational Journal of Innovation Management
researchProduct

How strategic needs influence alliance formation and their governance modes: An empirical study in the Italian biopharmaceutical industry

2011

Firms enter strategic alliances for various reasons, and the motives behind formation of these alliances are one of main research subjects in the management field. The large literature on the issue has highlighted how alliances answer to a strategic need for collaboration that is the need to improve competitive strength through collaboration agreements. However, the study here addresses the strategic need perspective to alliances under a more specific point of view. We question what kind of competitive strengths firms aim at acquiring through inter-firm relationships. By reviewing of the most relevant literature on the issue we assume that alliances respond to three principal strategic need…

governance modestrategic alliancebiopharmaceutical industrysurveygeneralized ordered logit modelsSettore ING-IND/35 - Ingegneria Economico-Gestionalealliance formation
researchProduct

Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects

2019

In this work, 13 jet nebulizers, some of which in different configurations, were investigated in order to identify the biopharmaceutical constraints related to the quality attributes of the medicinal products, which affect their safety, efficiency, compliance, and effectiveness. The aerosolization parameters, including the aerosol output, aerosol output rate, mass median aerodynamic diameter, and fine particle fraction, were determined according to the European Standard EN 13544-1, using sodium fluoride as a reference formulation. A comparison between the aerosol output nebulization time and the fine particle fraction displayed a correlation between the aerosol quality and the nebulization …

respirable dose delivery ratePharmaceutical SciencePatient characteristicslcsh:RS1-441030226 pharmacology & pharmacycomplex mixturesArticleNOlcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineAerosol output Aerosol output rate Fine particle fraction Mass median aerodynamic diameter Nebulizers Respirable delivered dose Respirable dose delivery rateAerosolizationaerosol output raterespirable delivered dosemass median aerodynamic diameterDose deliveryJet (fluid)aerosol outputrespiratory systemAerosolNebulizerBiopharmaceutical030228 respiratory systemEnvironmental sciencefine particle fractionnebulizersBiomedical engineeringParticle fractionPharmaceutics
researchProduct